(2E)-1-(3-methoxyphenyl)-3-(3-methylthiophen-2-yl)prop-2-en-1-one, 95.0%, 2g

Monostéarate de glycérol, pur, 500 g, emballage plastique.

5-((tert-Butoxycarbonyl)amino)-4-oxopentanoic acid, 95.0%, 100mg

[1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]acetic acid, 250mg

5-Oxo-5 H -thiazolo[3,2- a ]pyrimidine-6-carboxylic acid, 95.0%, 5g

2-(Benzyloxy)-1-bromo-6-methoxynaphthalene, 98%, 1g

2-([1,1':3',1''-Terphenyl]-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

2-(2-Chloro-6-fluorobenzyl)isoindoline-1,3-dione, 98%, 500mg

(4-Chlorophenyl)(piperidin-4-yl)methanol hydrochloride, 98%, 500mg

2-METHYLINDAZOLE-7-BORONIC ACID, 95.0%, 100mg

Dimethyl [2,2'-bipyridine]-4,4'-dicarboxylate, 95.0%, 25g

6-Bromo-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine, 98%, 1g

3-(Trimethylsilyl)naphthalen-2-yl trifluoromethanesulfonate, 97%, 5g